← All indications
Esophagitis, Peptic
INFLAMMATION of the ESOPHAGUS that is caused by the reflux of GASTRIC JUICE with contents of the STOMACH and DUODENUM.
Drugs by status
Phase 4 trials (4)
Phase 3 trials (4)
Phase 2 trials (4)
Phase 1 trials (1)
Other trials (1)
Organizations
Organization Involved with Phase 4 Indications (38)
- Eisai
- Takeda
- Bausch Health Companies
- AstraZeneca
- Wyeth
- Parexel
- Altana
- Chong Kun Dang Pharmaceutical
- Otsuka
- Dr. Falk Pharma GmbH
- Severance Hospital
- Eastern Virginia Medical School
- Lotung Poh-Ai Hospital
- National Cheng Kung University
- Russian Academy of Medical Sciences
- Shaanxi Provincial People's Hospital
- University of Iowa
- University of Milan
- University of Pavia
- Yonsei University
- Mayo Clinic
- Capital Medical University
- University of Cincinnati
- Kangaroo Foundation
- Konyang University
- Janssen Pharmaceutica NV
- Soonchunhyang University
- Kyungpook University
- Pontificia Universidad Javeriana
- Centre for Primary and Community Care, Sunderland, United Kingdom
- +8 more
Organization Involved with Phase 3 Indications (26)
- Ironwood Pharmaceuticals
- Astellas
- Pfizer
- Novartis
- Braintree Laboratories
- Eurofarma Laboratorios S.A.
- Livzon Pharmaceutical Group Inc.
- Nycomed
- Norgine
- Ahn-Gook Pharmaceuticals Co.,Ltd
- Hoosier Cancer Research Network
- Inje University
- Juntendo University
- Korea University
- Seoul National University
- Tohoku University
- University of Science Malaysia
- Chinese University of Hong Kong
- University of Ulsan
- Karolinska Institute
- Warsaw University
- Catholic University of Korea
- University of Texas at Houston
- KhonKaen University
- Sungkyunkwan University
- The University of Texas, Dallas
Organization Involved with Phase 2 Indications (18)
- Zeria Pharmaceutical
- XenoPort, Inc.
- Shire
- Edusa Pharmaceuticals, Inc.
- Indivior Inc.
- Ocera Therapeutics
- Steba Biotech S.A.
- Stanford University
- University of Alberta
- Peking University
- University of Amsterdam
- Oklahoma Foundation for Digestive Research
- Addex Pharma
- Free University of Brussels
- University of Brussels
- Department of Veteran Affairs
- Yuhan Pharmaceutical Company
- Sinorda Biomedicine
Organization Involved with Phase 1 Indications (7)
Organization Involved with Other Experimental Indications (4)